Rank 32 • AI & Clinical Intelligence
RapidAI
Delivers clinical AI imaging software for neurovascular and vascular conditions, helping physicians make fast, accurate treatment decisions.
Visit website- Signal Score
- 89.5
- Total raised
- $100M
- Stage
- Series C
- Founded
- 2012
- Headquarters
- San Mateo, USA
- Region
- North America
Their signal
An industry pioneer in stroke care, RapidAI is installed in thousands of hospitals globally, providing crucial real-time imaging analysis that speeds up life-saving interventions.
Signal Score 89.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.